BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu Y, Cai O, Wu P, Tan S. MiR‐490‐5p inhibits the stemness of hepatocellular carcinoma cells by targeting ECT2. J Cell Biochem 2019;120:967-76. [DOI: 10.1002/jcb.27459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao J, Dai C, Yu X, Yin XB, Zhou F. Upregulated microRNA-194 impairs stemness of cholangiocarcinoma cells through the Rho pathway via inhibition of ECT2. J Cell Biochem 2020;121:4239-50. [PMID: 31960990 DOI: 10.1002/jcb.29648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Li J, Xu X, Liu C, Xi X, Wang Y, Wu X, Li H. MiR-490-5p Restrains Progression of Gastric cancer through DTL Repression. Gastroenterol Res Pract 2021;2021:2894117. [PMID: 34594374 DOI: 10.1155/2021/2894117] [Reference Citation Analysis]
3 Li Y, Tian D, Chen H, Cai Y, Chen S, Duan S. MicroRNA-490-3p and -490-5p in carcinogenesis: Separate or the same goal? Oncol Lett 2021;22:678. [PMID: 34345303 DOI: 10.3892/ol.2021.12939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Xu D, Wang Y, Wu J, Zhang Z, Chen J, Xie M, Tang R, Chen C, Chen L, Lin S, Luo X, Zheng J. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway. Cell Death Dis 2021;12:162. [PMID: 33558466 DOI: 10.1038/s41419-021-03450-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhang H, Geng Y, Sun C, Yu J. Upregulation of ECT2 Predicts Adverse Clinical Outcomes and Increases 5-Fluorouracil Resistance in Gastric Cancer Patients. J Oncol 2021;2021:2102890. [PMID: 34367280 DOI: 10.1155/2021/2102890] [Reference Citation Analysis]
6 Qiao Y, Pei Y, Luo M, Rajasekaran M, Hui KM, Chen J. Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma. Exp Biol Med (Maywood) 2021;246:1343-54. [PMID: 33899543 DOI: 10.1177/15353702211008380] [Reference Citation Analysis]
7 Li B, Lin JP, Li Z, Yin C, Yang JB, Meng YQ. Clinicopathological and prognostic significance of epithelial cell transforming sequence 2 expression in cancers: a systematic review and meta-analysis. Artif Cells Nanomed Biotechnol 2019;47:4139-48. [PMID: 31698961 DOI: 10.1080/21691401.2019.1687503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Vinchure OS, Kulshreshtha R. miR-490: A potential biomarker and therapeutic target in cancer and other diseases. J Cell Physiol 2021;236:3178-93. [PMID: 33094503 DOI: 10.1002/jcp.30119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]